Sign inJoin waitlistJoin the waitlist

Gino In

Hematology & Oncology · Usc Care Medical Group Inc

Credentials: · ·

History

Hematology and Medical Oncology
University of Southern California/Los Angeles General Medical Center
2014–2017
University of Southern California/Los Angeles General Medical Center
2011–2014
SUNY Downstate Medical Center
2008–2011
Doctor of Medicine
2006–2010

Research

Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
New England Journal of Medicine · 2023 · 739 citations
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance
Nature Communications · 2019 · 141 citations
Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database
Experimental Biology and Medicine · 2021 · 111 citations

Jenny Hu
10 papers
Geoffrey Gibney
9 papers
Brittney DeClerck
7 papers
OR
Omar Ragab
6 papers
Binh Ngo
5 papers
David Freyer
5 papers
David Peng
5 papers
Fumito Ito
5 papers
AV
Ari Vanderwalde
4 papers
AM
Arjun Mehta
4 papers · 1 as a fellow
Bartosz Chmielowski
4 papers
Jesse Berry
4 papers · 1 as a resident

Clinical trials

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
Principal investigator · Active not recruiting · Phase 1
University of Southern California
2020–2028
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
Principal investigator · Active not recruiting · Phase 2
University of Southern California
2020–2027
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2024–2027
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Site PI · Recruiting · Phase 3
Replimune, Inc.
2024–2031